Ankit Mishra*
Assistant Professor, Department of Otorhinolaryngology Head and Neck Surgery, LN Medical College and JK Hospital, Bhopal, MP, India
*Corresponding Author: Ankit Mishra, Assistant Professor, Department of Otorhinolaryngology Head and Neck surgery, LN Medical College and JK Hospital, Bhopal, MP, India.
Received: July 23, 2021; Published: October 01, 2021
Malignant melanoma is comparatively a rare malignancy whose prevalence is nearly 1 - 2% of whole-body malignancies. Out of these, 90% are skin malignancies. Melanomas are malignant neoplasms, they are derived from melanocytes, a neuroectodermal derivatives located in the basal layer of the skin. Malignant melanomas in the head and neck mucosal surfaces are quite rare, which account for < 1% of all melanomas. Malignant melanoma of sinonasal region accounts for 1% of all mucosal melanomas and 3 - 4% of malignant neoplasms of the sinonasal tract. They originate from melanocytes present in mucous membranes, in glands, superficial and deep stroma of septum and turbinates, bones like maxilla and ethmoids. Due to late presentation at an advanced stage, these have a significantly low 5-year survival.
Citation: Ankit Mishra. “Primary Sinonasal Malignant Melanoma: Diagnosis to Prognosis".Acta Scientific Otolaryngology 3.11 (2021): 01-02.
Copyright: © 2021 Ankit Mishra. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.